Epilepsy, Alzheimers & Parkinson's Drug Development
Upsher-Smith Laboratories, Inc., is a privately held, specialty pharmaceutical company with headquarters in Minneapolis, MN (www.upsher-smith.com). The company is seeking collaborative partners and out-licensing opportunities for improved drug therapies that treat epilepsy, Parkinson's and Alzheimer's disease. Background
Upsher-Smith Laboratories, Inc., a privately held, specialty pharmaceutical company with headquarters in Minneapolis, MN (www.upsher-smith.com), is pursuing improved drug therapies to empower people suffering from diseases to lead healthy productive lives. Upsher-Smith is actively pursuing development opportunities in the therapeutic areas of epilepsy and Parkinson’s disease and is seeking to do business with innovative Canadian organizations. The company, in partnership with the Consulate General of Canada Minneapolis, is seeking novel drug development opportunities and products. Upsher-Smith is flexible and open to a variety of collaborative partnerships.
Upsher-Smith is committed to the development and growth of innovative products. Our focus is simple: “Advancing pharmacotherapy. Improving life.™”
Upsher-Smith is focused within the CNS category on specific therapeutic areas with significant unmet need including epilepsy, Parkinson’s disease and Alzheimer’s disease. Upsher-Smith is currently seeking partnership opportunities in these therapeutic areas, specifically:
· New molecular entities within epilepsy and Parkinson’s disease across all stages of development from preclinical through phase III.
· Novel reformulations of existing compounds which expand the utility of the compound within the areas of epilepsy and Parkinson’s disease through improvements in safety, tolerability, efficacy, compliance or patient acceptance.
Upsher-Smith is interested in exploring multiple partnership structures, including licensing, acquisition, co-development, co-marketing, joint ventures and profit sharing.
How to Participate:
Review Upsher-Smith Laboratory’s areas of interest and identify those that match your organization’s technologies whether existing or under development; Ensure that your organization has relevant published papers, presentation materials and/or patents that can be reviewed by the Upsher-Smith evaluators; Contact Andy Melnyk email@example.com at the Consulate General of Canada Minneapolis with your expression of interest and you will be provided with a basic template for completion; All expressions of interest must be submitted via e-mail to firstname.lastname@example.org no later than December 31, 2008; Upsher-Smith Laboratory will review all submissions to determine those of specific interest for future follow-up.
Type of Offer:
« More Healthcare Patents« More Life Sciences Patents